U.S. Markets closed

Brooklyn ImmunoTherapeutics, Inc. (BTX)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
11.45+0.39 (+3.53%)
At close: 3:59PM EDT
11.53 +0.08 (0.70%)
After hours: 07:24PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 380.67
52 Week Low 33.04
50-Day Moving Average 314.02
200-Day Moving Average 313.77

Share Statistics

Avg Vol (3 month) 34.38M
Avg Vol (10 day) 31.07M
Shares Outstanding 542.68M
Implied Shares Outstanding 6N/A
Float 20.58M
% Held by Insiders 155.50%
% Held by Institutions 10.37%
Shares Short (May 27, 2021) 4667.61k
Short Ratio (May 27, 2021) 40.05
Short % of Float (May 27, 2021) 4N/A
Short % of Shares Outstanding (May 27, 2021) 41.56%
Shares Short (prior month Apr 29, 2021) 4939.15k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:2
Last Split Date 3Mar 25, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-7.88M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.41M
Total Cash Per Share (mrq)0.2
Total Debt (mrq)2.83M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.51
Book Value Per Share (mrq)-0.11

Cash Flow Statement

Operating Cash Flow (ttm)-8.06M
Levered Free Cash Flow (ttm)N/A